Understanding HIV prevention for incarcerated individuals in Zambia
Prison PrEP Values Adherence and Implementation in Lusaka (PrEVAIL)
['FUNDING_R21'] · UNIVERSITY OF MARYLAND BALTIMORE · NIH-10819509
This study is looking at how to best provide HIV prevention medication, called PrEP, to people in prison in Lusaka, Zambia, who are at high risk for HIV, and it wants to understand how they use it while in jail and after they get out.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MARYLAND BALTIMORE (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10819509 on ClinicalTrials.gov |
What this research studies
This research investigates how to effectively provide pre-exposure prophylaxis (PrEP) to incarcerated individuals in Lusaka, Zambia, who are at high risk for HIV. It aims to understand the patterns of PrEP uptake, adherence, and persistence among these individuals during their time in prison and as they transition back to the community. By examining their perceptions of HIV risk and behaviors, the study seeks to optimize the timing and delivery of PrEP as part of a comprehensive prevention strategy. The research builds on previous studies focused on health services for incarcerated populations in sub-Saharan Africa.
Who could benefit from this research
Good fit: Ideal candidates for this research are incarcerated individuals in Zambia who are at risk for HIV.
Not a fit: Patients who are not incarcerated or who do not have a risk of HIV infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce HIV transmission rates among incarcerated individuals and improve their overall health outcomes.
How similar studies have performed: Previous studies have shown success in implementing HIV prevention strategies in incarcerated populations, indicating that this approach has potential.
Where this research is happening
BALTIMORE, UNITED STATES
- UNIVERSITY OF MARYLAND BALTIMORE — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CLAASSEN, CASSIDY W. — UNIVERSITY OF MARYLAND BALTIMORE
- Study coordinator: CLAASSEN, CASSIDY W.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus